Your body needs time to adjust
That determination is the provider's call, not the platform's
Ali Guler of the University of Virginia says when GLP-1 is delivered to this brain area in mice, it doesn't affect their appetite for healthy foods
SS-31 (elamipretide) , a mitochondria-targeted peptide that stabilizes cardiolipin to support energy production, became the first FDA-approved mitochondrial therapeutic in 2025, though only for the rare Barth syndrome, with the brain rationale still mechanistic and no cognitive trials
A: The recommended frequency depends on your personal health goals
Supporting people in their nutritional needs is what our industry has done a good job at, and now retailers can really support people on the GLP-1 journey.